Exclusively for CNBC Pro Subscribers - Goldman says now is the time to buy this stock
Now is the time to buy this biotech company as shares could jump more than 75% from here, Goldman Sachs said. Shares of this stock have plummeted more than 64% this year, but Goldman's price target suggests shares could rally nearly 76% from Tuesday's close price. Subscribe to CNBC Pro to see which stock Goldman Sachs thinks could rally after dipping this year. | | | Here are more of today's top stories, exclusive for CNBC Pro subscribers! CNBC Pro Talks: Fundstrat's Tom Lee says a market rally is coming in the second half. This is how to play it
TUE, AUGUST 02 2022 Finding cheap stocks that are buying back their own shares, based on David Einhorn's methodology
TUE, AUGUST 02 2022 Bank of America says these are the banks to own during uncertain times
TUE, AUGUST 02 2022 Here are Tuesday's biggest analyst calls: Tesla, Apple, Snowflake, Wayfair, Pinterest, Ross & more
TUE, AUGUST 02 2022 Wall Street pros say these small caps are good buys as recession looms — BofA gives one 40% upside
WED, AUGUST 03 2022 These stocks are the key to the market going higher for the rest of the summer
TUE, AUGUST 02 2022 | | | | | Like getting these emails? Subscribe to CNBC Pro today and get access to unlimited Pro articles, access to Pro live events, stock tips, and money-making investment ideas. | | | © 2022 CNBC LLC. All rights reserved. A property of NBCUniversal. 900 Sylvan Avenue, Englewood Cliffs, NJ 07632 Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes and Market Data and Analysis. Data also provided by THOMSON REUTERS | | | |
No comments:
Post a Comment